ALIM Annual CFF
$96.50 M
+$96.80 M+32053.31%
31 December 2023
Summary:
As of January 28, 2025, ALIM annual cash flow from financing activities is $96.50 million, with the most recent change of +$96.80 million (+32053.31%) on December 31, 2023. During the last 3 years, it has risen by +$92.62 million (+2385.81%).ALIM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALIM Quarterly CFF
-$4.32 M
-$7.28 M-245.43%
30 June 2024
Summary:
As of January 28, 2025, ALIM quarterly cash flow from financing activities is -$4.32 million, with the most recent change of -$7.28 million (-245.43%) on June 30, 2024. Over the past year, it has dropped by -$3.77 million (-690.29%).ALIM Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALIM TTM CFF
-$1.97 M
-$91.44 M-102.20%
30 June 2024
Summary:
As of January 28, 2025, ALIM TTM cash flow from financing activities is -$1.97 million, with the most recent change of -$91.44 million (-102.20%) on June 30, 2024. Over the past year, it has dropped by -$98.36 million (-102.05%).ALIM TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALIM Cash From Financing Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +10000.0% | -690.3% | -102.0% |
3 y3 years | +2385.8% | -143.4% | -120.3% |
5 y5 years | +10000.0% | -7339.7% | -326.9% |
ALIM Cash From Financing High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time | -15.9% | -105.0% | -101.7% |
Alimera Sciences Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2024 | - | -$4.32 M(-245.4%) | -$1.97 M(-102.2%) |
Mar 2024 | - | $2.97 M(-3903.8%) | $89.47 M(-7.3%) |
Dec 2023 | $96.50 M(<-9900.0%) | -$78.00 K(-85.7%) | $96.50 M(+0.1%) |
Sept 2023 | - | -$546.00 K(-100.6%) | $96.38 M(-0.6%) |
June 2023 | - | $87.13 M(+771.4%) | $96.98 M(+893.9%) |
Mar 2023 | - | $10.00 M(-5280.3%) | $9.76 M(-3331.1%) |
Dec 2022 | -$302.00 K(-103.1%) | -$193.00 K(-450.9%) | -$302.00 K(+135.9%) |
Sept 2022 | - | $55.00 K(-153.9%) | -$128.00 K(-44.8%) |
June 2022 | - | -$102.00 K(+64.5%) | -$232.00 K(-102.4%) |
Mar 2022 | - | -$62.00 K(+226.3%) | $9.82 M(-0.1%) |
Dec 2021 | $9.82 M(+153.0%) | -$19.00 K(-61.2%) | $9.82 M(+0.3%) |
Sept 2021 | - | -$49.00 K(-100.5%) | $9.80 M(+0.6%) |
June 2021 | - | $9.95 M(<-9900.0%) | $9.73 M(+590.4%) |
Mar 2021 | - | -$57.00 K(+23.9%) | $1.41 M(-63.7%) |
Dec 2020 | $3.88 M(+346.7%) | -$46.00 K(-58.2%) | $3.88 M(-22.3%) |
Sept 2020 | - | -$110.00 K(-106.8%) | $5.00 M(-1.0%) |
June 2020 | - | $1.62 M(-32.8%) | $5.05 M(+48.8%) |
Mar 2020 | - | $2.42 M(+125.9%) | $3.39 M(+290.6%) |
Dec 2019 | $869.00 K(-8.5%) | $1.07 M(-1943.1%) | $869.00 K(-486.2%) |
Sept 2019 | - | -$58.00 K(+81.3%) | -$225.00 K(-39.2%) |
June 2019 | - | -$32.00 K(-70.9%) | -$370.00 K(-5.9%) |
Mar 2019 | - | -$110.00 K(+340.0%) | -$393.00 K(-141.4%) |
Dec 2018 | $950.00 K(-83.4%) | -$25.00 K(-87.7%) | $950.00 K(+0.5%) |
Sept 2018 | - | -$203.00 K(+269.1%) | $945.00 K(-76.6%) |
June 2018 | - | -$55.00 K(-104.5%) | $4.04 M(-42.3%) |
Mar 2018 | - | $1.23 M(-4210.0%) | $6.99 M(+22.2%) |
Dec 2017 | $5.72 M(-77.5%) | -$30.00 K(-101.0%) | $5.72 M(+2.3%) |
Sept 2017 | - | $2.89 M(-0.3%) | $5.59 M(-80.3%) |
June 2017 | - | $2.90 M(-7728.9%) | $28.44 M(+10.0%) |
Mar 2017 | - | -$38.00 K(-76.3%) | $25.85 M(+1.7%) |
Dec 2016 | $25.42 M(+3967.8%) | -$160.00 K(-100.6%) | $25.42 M(-3.8%) |
Sept 2016 | - | $25.74 M(+8257.8%) | $26.42 M(+3358.5%) |
June 2016 | - | $308.00 K(-166.1%) | $764.00 K(+109.9%) |
Mar 2016 | - | -$466.00 K(-155.5%) | $364.00 K(-41.8%) |
Dec 2015 | $625.00 K | $839.00 K(+910.8%) | $625.00 K(-98.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2015 | - | $83.00 K(-190.2%) | $49.80 M(-33.4%) |
June 2015 | - | -$92.00 K(-55.1%) | $74.72 M(-6.1%) |
Mar 2015 | - | -$205.00 K(-100.4%) | $79.56 M(-30.7%) |
Dec 2014 | $114.75 M(+6837.4%) | $50.01 M(+100.0%) | $114.75 M(+77.6%) |
Sept 2014 | - | $25.00 M(+426.1%) | $64.63 M(+63.2%) |
June 2014 | - | $4.75 M(-86.4%) | $39.59 M(+6.7%) |
Mar 2014 | - | $34.98 M(<-9900.0%) | $37.09 M(+2142.7%) |
Dec 2013 | $1.65 M(-95.5%) | -$107.00 K(+214.7%) | $1.65 M(-95.9%) |
Sept 2013 | - | -$34.00 K(-101.5%) | $40.66 M(+1.2%) |
June 2013 | - | $2.26 M(-588.5%) | $40.20 M(+7.9%) |
Mar 2013 | - | -$462.00 K(-101.2%) | $37.27 M(+0.3%) |
Dec 2012 | $37.16 M(-9163.7%) | $38.90 M(-7896.2%) | $37.16 M(-1813.3%) |
Sept 2012 | - | -$499.00 K(-25.7%) | -$2.17 M(+14.2%) |
June 2012 | - | -$672.00 K(+17.7%) | -$1.90 M(+74.1%) |
Mar 2012 | - | -$571.00 K(+33.7%) | -$1.09 M(+166.1%) |
Dec 2011 | -$410.00 K(-100.6%) | -$427.00 K(+86.5%) | -$410.00 K(-106.6%) |
Sept 2011 | - | -$229.00 K(-268.4%) | $6.22 M(-0.5%) |
June 2011 | - | $136.00 K(+23.6%) | $6.26 M(-89.3%) |
Mar 2011 | - | $110.00 K(-98.2%) | $58.30 M(-14.5%) |
Dec 2010 | $68.17 M(+1386.5%) | $6.21 M(-3251.3%) | $68.17 M(+10.6%) |
Sept 2010 | - | -$197.00 K(-100.4%) | $61.65 M(-7.6%) |
June 2010 | - | $52.18 M(+422.7%) | $66.75 M(+358.1%) |
Mar 2010 | - | $9.98 M(-3309.6%) | $14.57 M(+217.7%) |
Dec 2009 | $4.59 M(-84.6%) | -$311.00 K(-106.3%) | $4.59 M(-6.3%) |
Sept 2009 | - | $4.90 M(<-9900.0%) | $4.90 M(-4284.6%) |
June 2009 | - | -$3000.00(0.0%) | -$117.00 K(-108.3%) |
Mar 2009 | - | -$3000.00(+200.0%) | $1.41 M(-95.3%) |
Dec 2008 | $29.78 M(>+9900.0%) | -$1000.00(-99.1%) | $29.78 M(-0.0%) |
Sept 2008 | - | -$110.00 K(-107.2%) | $29.79 M(-0.4%) |
June 2008 | - | $1.52 M(-94.6%) | $29.89 M(+5.4%) |
Mar 2008 | - | $28.37 M(<-9900.0%) | $28.37 M(>+9900.0%) |
Dec 2007 | $80.00 K(-99.5%) | - | - |
June 2007 | - | -$2000.00(-103.3%) | $58.00 K(-3.3%) |
Mar 2007 | - | $60.00 K | $60.00 K |
Dec 2006 | $15.82 M | - | - |
FAQ
- What is Alimera Sciences annual cash flow from financing activities?
- What is the all time high annual CFF for Alimera Sciences?
- What is Alimera Sciences annual CFF year-on-year change?
- What is Alimera Sciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Alimera Sciences?
- What is Alimera Sciences quarterly CFF year-on-year change?
- What is Alimera Sciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Alimera Sciences?
- What is Alimera Sciences TTM CFF year-on-year change?
What is Alimera Sciences annual cash flow from financing activities?
The current annual CFF of ALIM is $96.50 M
What is the all time high annual CFF for Alimera Sciences?
Alimera Sciences all-time high annual cash flow from financing activities is $114.75 M
What is Alimera Sciences annual CFF year-on-year change?
Over the past year, ALIM annual cash flow from financing activities has changed by +$96.80 M (+32053.31%)
What is Alimera Sciences quarterly cash flow from financing activities?
The current quarterly CFF of ALIM is -$4.32 M
What is the all time high quarterly CFF for Alimera Sciences?
Alimera Sciences all-time high quarterly cash flow from financing activities is $87.13 M
What is Alimera Sciences quarterly CFF year-on-year change?
Over the past year, ALIM quarterly cash flow from financing activities has changed by -$3.77 M (-690.29%)
What is Alimera Sciences TTM cash flow from financing activities?
The current TTM CFF of ALIM is -$1.97 M
What is the all time high TTM CFF for Alimera Sciences?
Alimera Sciences all-time high TTM cash flow from financing activities is $114.75 M
What is Alimera Sciences TTM CFF year-on-year change?
Over the past year, ALIM TTM cash flow from financing activities has changed by -$98.36 M (-102.05%)